New Results
Chemical inhibition of prolyl hydroxylases impairs angiogenic competence of human vascular endothelium through metabolic reprogramming
Ratnakar Tiwari, Prashant V. Bommi, Peng Gao, Matthew J. Schipma, Yalu Zhou, Susan E. Quaggin, Navdeep S. Chandel, Pinelopi P. Kapitsinou
doi: https://doi.org/10.1101/2022.03.25.485858
Ratnakar Tiwari
1Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL
2Division of Nephrology & Hypertension, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Prashant V. Bommi
1Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL
2Division of Nephrology & Hypertension, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Peng Gao
3Department of Medicine and Robert H. Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
Matthew J. Schipma
4Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL
Yalu Zhou
1Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL
2Division of Nephrology & Hypertension, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Susan E. Quaggin
1Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL
2Division of Nephrology & Hypertension, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Navdeep S. Chandel
3Department of Medicine and Robert H. Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
Pinelopi P. Kapitsinou
1Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL
2Division of Nephrology & Hypertension, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
3Department of Medicine and Robert H. Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
Article usage
Posted March 26, 2022.
Chemical inhibition of prolyl hydroxylases impairs angiogenic competence of human vascular endothelium through metabolic reprogramming
Ratnakar Tiwari, Prashant V. Bommi, Peng Gao, Matthew J. Schipma, Yalu Zhou, Susan E. Quaggin, Navdeep S. Chandel, Pinelopi P. Kapitsinou
bioRxiv 2022.03.25.485858; doi: https://doi.org/10.1101/2022.03.25.485858
Chemical inhibition of prolyl hydroxylases impairs angiogenic competence of human vascular endothelium through metabolic reprogramming
Ratnakar Tiwari, Prashant V. Bommi, Peng Gao, Matthew J. Schipma, Yalu Zhou, Susan E. Quaggin, Navdeep S. Chandel, Pinelopi P. Kapitsinou
bioRxiv 2022.03.25.485858; doi: https://doi.org/10.1101/2022.03.25.485858
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8751)
- Bioinformatics (29195)
- Biophysics (14971)
- Cancer Biology (12095)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18306)
- Genetics (12245)
- Genomics (16801)
- Immunology (11867)
- Microbiology (28083)
- Molecular Biology (11592)
- Neuroscience (60965)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7339)
- Zoology (1651)